Skip to content
Clinical Trials – home
IRCCS Istituto Giannina Gaslini
Sponsor

IRCCS Istituto Giannina Gaslini

Italy Via Gerolamo Gaslini 5, 16147 Genoa, Italy

About the sponsor

Clinical research in juvenile idiopathic arthritis and recurrent pericarditis includes treatment strategies for disease control, flare prevention, and targeted anti-inflammatory therapy in children and adolescents.

  • Juvenile idiopathic arthritis
  • Recurrent pericarditis
  • PAPA syndrome
  • IL-1 blockade

Work in this area also covers biomarker-informed treatment decisions and the management of inflammatory conditions that are resistant to standard anti-rheumatic therapy.

About Specializations

IRCCS Istituto Giannina Gaslini runs clinical trials in conditions such as General anaesthesia, Juvenile idiopathic arthritis, Cystic fibrosis, Neuroblastoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

11 clinical trials

Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Elexacaftor
  • Sponsor:IRCCS Istituto Giannina Gaslini
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Rocuronium Bromide
  • Sponsor:IRCCS Istituto Giannina Gaslini
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years
  • Substances:Dinutuximab Beta
  • Sponsor:IRCCS Istituto Giannina Gaslini
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Clonidine Hydrochloride
  • Sponsor:IRCCS Istituto Giannina Gaslini
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years
  • Sponsor:IRCCS Istituto Giannina Gaslini
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Etanercept
  • Sponsor:IRCCS Istituto Giannina Gaslini
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Anakinra
  • Sponsor:IRCCS Istituto Giannina Gaslini
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Substances:Abatacept
  • Sponsor:IRCCS Istituto Giannina Gaslini

Neutropenia

Not yet recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years
  • Substances:Pegfilgrastim
  • Sponsor:IRCCS Istituto Giannina Gaslini
Registered drug
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Canakinumab
  • Sponsor:IRCCS Istituto Giannina Gaslini
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Sevoflurane
  • Sponsor:IRCCS Istituto Giannina Gaslini

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.